← USPTO Patent Applications

ROD-DERIVED CONE VIABILITY FACTOR FUSION PROTEIN

Application US20260091133A1 Kind: A1 Apr 02, 2026

Inventors

Tianci LUO, Daniel LIPUT, Fong Qi LIANG

Abstract

The present invention relates to a fusion protein comprising a) a short rod-derived cone viability factor (RdCVF-S), b) a hydrophilic peptide, and c) a signal peptide, along with the nucleic acids encoding those peptides and viral vectors containing these nucleic acids. The invention also relates to compositions and pharmaceutical preparations comprising these nucleic acids or vectors, methods of producing or secreting the fusion protein comprising RdCVF-S protein, an immunoglobulin constant region, and a human signal sequence, and methods of treatment.

CPC Classifications

A61K 48/005 A61K 48/0075 A61P 27/02 C07K 14/4702 C12N 15/62 C12N 15/86 A61K 38/00 C07K 2319/02 C07K 2319/30 C12N 2750/14143

Filing Date

2025-09-25

Application No.

19339969